Action Point Financial Planning’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,749
Closed -$158K – 680
2026
Q2
$158K Buy
+2,749
New +$158K 0.02% 493

Other funds holding BMY

Action Point Financial Planning's BMY Position: Q3 2026 in Review

Action Point Financial Planning sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 2,749 shares — an estimated $158K sold.

Action Point Financial Planning first reported a position in BMY in Q2 2026 and held it in 1 quarter. The position peaked at $158K in Q2 2026. 2,568 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Action Point Financial Planning reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 2,749 Bristol-Myers Squibb shares in Q3 2026, an estimated $158K.
  • Action Point Financial Planning first reported a position in Bristol-Myers Squibb in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's Bristol-Myers Squibb position peaked at $158K in Q2 2026.
  • 2,568 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.